Loading…

Migraine and invasive epithelial ovarian cancer risk in the Nurses’ Health Study II and the Women's Health Study

Migraine is a common primary headache disorder, which predominantly impacts women. Recently, migraine has been hypothesized to be associated with hormonally related cancers; however, the potential association between migraine and ovarian cancer has not been studied. Therefore, we evaluated the assoc...

Full description

Saved in:
Bibliographic Details
Published in:International journal of cancer 2018-02, Vol.142 (3), p.534-539
Main Authors: Rice, Megan S., Rist, Pamela M., Winter, Anke C., Kurth, Tobias, Tworoger, Shelley S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4432-54f6b192ace3d58342999529f92e6d6bd872dd1baefd689cab91d22abe0b24cb3
cites cdi_FETCH-LOGICAL-c4432-54f6b192ace3d58342999529f92e6d6bd872dd1baefd689cab91d22abe0b24cb3
container_end_page 539
container_issue 3
container_start_page 534
container_title International journal of cancer
container_volume 142
creator Rice, Megan S.
Rist, Pamela M.
Winter, Anke C.
Kurth, Tobias
Tworoger, Shelley S.
description Migraine is a common primary headache disorder, which predominantly impacts women. Recently, migraine has been hypothesized to be associated with hormonally related cancers; however, the potential association between migraine and ovarian cancer has not been studied. Therefore, we evaluated the association between migraine and invasive epithelial ovarian cancer risk in two prospective cohorts, the Nurses’ Health Study II (NHSII) and the Women's Health Study (WHS). Our prospective analysis included 113,124 NHSII participants aged 25–42 at study baseline as well as 33,490 participants in the WHS who were 45 years or older at study entry. We used Cox proportional hazards models to estimate the hazard ratios (HR) and 95% confidence intervals (CIs) for the association between migraine and ovarian cancer risk in each cohort. In secondary analyses, we stratified by age and menopausal status. After adjusting for potential covariates, there was no statistically significant association between migraine and ovarian cancer risk in either the NHSII (HR = 1.29, 95%CI: 0.96, 1.74) or the WHS (HR = 0.60, 95%CI: 0.34, 1.06). In stratified analysis in the NHSII, there was a statistically significant positive association between migraine and ovarian cancer risk among women
doi_str_mv 10.1002/ijc.31062
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5856461</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1974479896</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4432-54f6b192ace3d58342999529f92e6d6bd872dd1baefd689cab91d22abe0b24cb3</originalsourceid><addsrcrecordid>eNp1kcFu1DAQhi0EotvCgRdAljhQDmltx3HiSyW0ArqowAEQR2tiT7pess5iJ4v2xmvwejwJbrdUFInTHP5Pn2bmJ-QJZyecMXHqV_ak5EyJe2TGma4LJnh1n8xyxoqal-qAHKa0YozzismH5EA0WmjZqBmJ7_xlBB-QQnDUhy0kv0WKGz8usffQ02EL0UOgFoLFSKNPXzNHc0zfTzFh-vXjJz1H6Mcl_ThObkcXi2vZFfFlWGN4nu7kj8iDDvqEj2_mEfn8-tWn-Xlx8eHNYv7yorBSlqKoZKdargVYLF3VlFJorSuhOy1QOdW6phbO8Rawc6rRFlrNnRDQImuFtG15RM723s3UrtFZDGOE3myiX0PcmQG8uZsEvzSXw9ZUTaWk4llwfCOIw7cJ02jWPlnsewg4TMlwLfO3WSVFRp_9g66GKYZ8XqZqKWvdaJWpF3vKxiGliN3tMpyZqyZNbtJcN5nZp39vf0v-qS4Dp3vgu-9x93-TWbyd75W_AZNnqdE</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1974479896</pqid></control><display><type>article</type><title>Migraine and invasive epithelial ovarian cancer risk in the Nurses’ Health Study II and the Women's Health Study</title><source>Wiley</source><creator>Rice, Megan S. ; Rist, Pamela M. ; Winter, Anke C. ; Kurth, Tobias ; Tworoger, Shelley S.</creator><creatorcontrib>Rice, Megan S. ; Rist, Pamela M. ; Winter, Anke C. ; Kurth, Tobias ; Tworoger, Shelley S.</creatorcontrib><description>Migraine is a common primary headache disorder, which predominantly impacts women. Recently, migraine has been hypothesized to be associated with hormonally related cancers; however, the potential association between migraine and ovarian cancer has not been studied. Therefore, we evaluated the association between migraine and invasive epithelial ovarian cancer risk in two prospective cohorts, the Nurses’ Health Study II (NHSII) and the Women's Health Study (WHS). Our prospective analysis included 113,124 NHSII participants aged 25–42 at study baseline as well as 33,490 participants in the WHS who were 45 years or older at study entry. We used Cox proportional hazards models to estimate the hazard ratios (HR) and 95% confidence intervals (CIs) for the association between migraine and ovarian cancer risk in each cohort. In secondary analyses, we stratified by age and menopausal status. After adjusting for potential covariates, there was no statistically significant association between migraine and ovarian cancer risk in either the NHSII (HR = 1.29, 95%CI: 0.96, 1.74) or the WHS (HR = 0.60, 95%CI: 0.34, 1.06). In stratified analysis in the NHSII, there was a statistically significant positive association between migraine and ovarian cancer risk among women &lt;45 years of age (HR = 1.76, 95%CI: 1.01, 3.07). We did not observe a clear association between migraine and ovarian cancer risk in two large prospective cohort studies. What's new? Migraine is more common in women than men, giving rise to the idea that hormones, particularly changing estrogen levels, trigger the condition. Recent studies further suggest that migraine may be associated with hormonally related cancers. Here, in two prospective cohorts, the Nurses’ Health Study II (NHSII), involving women ages 25–42 at baseline, and the Women's Health Study, with women 45 years or older, migraine was assessed for associations specifically with ovarian cancer. Overall, no statistically significant relationship was detected. Stratified analyses in the NHSII cohort revealed a positive association between migraine and ovarian cancer risk in women under age 45.</description><identifier>ISSN: 0020-7136</identifier><identifier>EISSN: 1097-0215</identifier><identifier>DOI: 10.1002/ijc.31062</identifier><identifier>PMID: 28929486</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Age ; Cancer ; Carcinoma, Ovarian Epithelial ; Cohort Studies ; Estrogens ; Female ; Headache ; Health risk assessment ; Health risks ; Humans ; Invasiveness ; Medical personnel ; Medical research ; Middle Aged ; Migraine ; Migraine Disorders - epidemiology ; Neoplasms, Glandular and Epithelial - epidemiology ; Nurses ; Nurses - statistics &amp; numerical data ; Ovarian cancer ; Ovarian carcinoma ; Ovarian Neoplasms - epidemiology ; Prospective Studies ; Risk ; Statistical analysis ; Statistical models ; Surveys and Questionnaires ; United States - epidemiology ; Women's Health ; Womens health</subject><ispartof>International journal of cancer, 2018-02, Vol.142 (3), p.534-539</ispartof><rights>2017 UICC</rights><rights>2017 UICC.</rights><rights>2018 UICC</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4432-54f6b192ace3d58342999529f92e6d6bd872dd1baefd689cab91d22abe0b24cb3</citedby><cites>FETCH-LOGICAL-c4432-54f6b192ace3d58342999529f92e6d6bd872dd1baefd689cab91d22abe0b24cb3</cites><orcidid>0000-0002-8900-4889</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28929486$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rice, Megan S.</creatorcontrib><creatorcontrib>Rist, Pamela M.</creatorcontrib><creatorcontrib>Winter, Anke C.</creatorcontrib><creatorcontrib>Kurth, Tobias</creatorcontrib><creatorcontrib>Tworoger, Shelley S.</creatorcontrib><title>Migraine and invasive epithelial ovarian cancer risk in the Nurses’ Health Study II and the Women's Health Study</title><title>International journal of cancer</title><addtitle>Int J Cancer</addtitle><description>Migraine is a common primary headache disorder, which predominantly impacts women. Recently, migraine has been hypothesized to be associated with hormonally related cancers; however, the potential association between migraine and ovarian cancer has not been studied. Therefore, we evaluated the association between migraine and invasive epithelial ovarian cancer risk in two prospective cohorts, the Nurses’ Health Study II (NHSII) and the Women's Health Study (WHS). Our prospective analysis included 113,124 NHSII participants aged 25–42 at study baseline as well as 33,490 participants in the WHS who were 45 years or older at study entry. We used Cox proportional hazards models to estimate the hazard ratios (HR) and 95% confidence intervals (CIs) for the association between migraine and ovarian cancer risk in each cohort. In secondary analyses, we stratified by age and menopausal status. After adjusting for potential covariates, there was no statistically significant association between migraine and ovarian cancer risk in either the NHSII (HR = 1.29, 95%CI: 0.96, 1.74) or the WHS (HR = 0.60, 95%CI: 0.34, 1.06). In stratified analysis in the NHSII, there was a statistically significant positive association between migraine and ovarian cancer risk among women &lt;45 years of age (HR = 1.76, 95%CI: 1.01, 3.07). We did not observe a clear association between migraine and ovarian cancer risk in two large prospective cohort studies. What's new? Migraine is more common in women than men, giving rise to the idea that hormones, particularly changing estrogen levels, trigger the condition. Recent studies further suggest that migraine may be associated with hormonally related cancers. Here, in two prospective cohorts, the Nurses’ Health Study II (NHSII), involving women ages 25–42 at baseline, and the Women's Health Study, with women 45 years or older, migraine was assessed for associations specifically with ovarian cancer. Overall, no statistically significant relationship was detected. Stratified analyses in the NHSII cohort revealed a positive association between migraine and ovarian cancer risk in women under age 45.</description><subject>Age</subject><subject>Cancer</subject><subject>Carcinoma, Ovarian Epithelial</subject><subject>Cohort Studies</subject><subject>Estrogens</subject><subject>Female</subject><subject>Headache</subject><subject>Health risk assessment</subject><subject>Health risks</subject><subject>Humans</subject><subject>Invasiveness</subject><subject>Medical personnel</subject><subject>Medical research</subject><subject>Middle Aged</subject><subject>Migraine</subject><subject>Migraine Disorders - epidemiology</subject><subject>Neoplasms, Glandular and Epithelial - epidemiology</subject><subject>Nurses</subject><subject>Nurses - statistics &amp; numerical data</subject><subject>Ovarian cancer</subject><subject>Ovarian carcinoma</subject><subject>Ovarian Neoplasms - epidemiology</subject><subject>Prospective Studies</subject><subject>Risk</subject><subject>Statistical analysis</subject><subject>Statistical models</subject><subject>Surveys and Questionnaires</subject><subject>United States - epidemiology</subject><subject>Women's Health</subject><subject>Womens health</subject><issn>0020-7136</issn><issn>1097-0215</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kcFu1DAQhi0EotvCgRdAljhQDmltx3HiSyW0ArqowAEQR2tiT7pess5iJ4v2xmvwejwJbrdUFInTHP5Pn2bmJ-QJZyecMXHqV_ak5EyJe2TGma4LJnh1n8xyxoqal-qAHKa0YozzismH5EA0WmjZqBmJ7_xlBB-QQnDUhy0kv0WKGz8usffQ02EL0UOgFoLFSKNPXzNHc0zfTzFh-vXjJz1H6Mcl_ThObkcXi2vZFfFlWGN4nu7kj8iDDvqEj2_mEfn8-tWn-Xlx8eHNYv7yorBSlqKoZKdargVYLF3VlFJorSuhOy1QOdW6phbO8Rawc6rRFlrNnRDQImuFtG15RM723s3UrtFZDGOE3myiX0PcmQG8uZsEvzSXw9ZUTaWk4llwfCOIw7cJ02jWPlnsewg4TMlwLfO3WSVFRp_9g66GKYZ8XqZqKWvdaJWpF3vKxiGliN3tMpyZqyZNbtJcN5nZp39vf0v-qS4Dp3vgu-9x93-TWbyd75W_AZNnqdE</recordid><startdate>20180201</startdate><enddate>20180201</enddate><creator>Rice, Megan S.</creator><creator>Rist, Pamela M.</creator><creator>Winter, Anke C.</creator><creator>Kurth, Tobias</creator><creator>Tworoger, Shelley S.</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TO</scope><scope>7U9</scope><scope>H94</scope><scope>K9.</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-8900-4889</orcidid></search><sort><creationdate>20180201</creationdate><title>Migraine and invasive epithelial ovarian cancer risk in the Nurses’ Health Study II and the Women's Health Study</title><author>Rice, Megan S. ; Rist, Pamela M. ; Winter, Anke C. ; Kurth, Tobias ; Tworoger, Shelley S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4432-54f6b192ace3d58342999529f92e6d6bd872dd1baefd689cab91d22abe0b24cb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Age</topic><topic>Cancer</topic><topic>Carcinoma, Ovarian Epithelial</topic><topic>Cohort Studies</topic><topic>Estrogens</topic><topic>Female</topic><topic>Headache</topic><topic>Health risk assessment</topic><topic>Health risks</topic><topic>Humans</topic><topic>Invasiveness</topic><topic>Medical personnel</topic><topic>Medical research</topic><topic>Middle Aged</topic><topic>Migraine</topic><topic>Migraine Disorders - epidemiology</topic><topic>Neoplasms, Glandular and Epithelial - epidemiology</topic><topic>Nurses</topic><topic>Nurses - statistics &amp; numerical data</topic><topic>Ovarian cancer</topic><topic>Ovarian carcinoma</topic><topic>Ovarian Neoplasms - epidemiology</topic><topic>Prospective Studies</topic><topic>Risk</topic><topic>Statistical analysis</topic><topic>Statistical models</topic><topic>Surveys and Questionnaires</topic><topic>United States - epidemiology</topic><topic>Women's Health</topic><topic>Womens health</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rice, Megan S.</creatorcontrib><creatorcontrib>Rist, Pamela M.</creatorcontrib><creatorcontrib>Winter, Anke C.</creatorcontrib><creatorcontrib>Kurth, Tobias</creatorcontrib><creatorcontrib>Tworoger, Shelley S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>International journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rice, Megan S.</au><au>Rist, Pamela M.</au><au>Winter, Anke C.</au><au>Kurth, Tobias</au><au>Tworoger, Shelley S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Migraine and invasive epithelial ovarian cancer risk in the Nurses’ Health Study II and the Women's Health Study</atitle><jtitle>International journal of cancer</jtitle><addtitle>Int J Cancer</addtitle><date>2018-02-01</date><risdate>2018</risdate><volume>142</volume><issue>3</issue><spage>534</spage><epage>539</epage><pages>534-539</pages><issn>0020-7136</issn><eissn>1097-0215</eissn><abstract>Migraine is a common primary headache disorder, which predominantly impacts women. Recently, migraine has been hypothesized to be associated with hormonally related cancers; however, the potential association between migraine and ovarian cancer has not been studied. Therefore, we evaluated the association between migraine and invasive epithelial ovarian cancer risk in two prospective cohorts, the Nurses’ Health Study II (NHSII) and the Women's Health Study (WHS). Our prospective analysis included 113,124 NHSII participants aged 25–42 at study baseline as well as 33,490 participants in the WHS who were 45 years or older at study entry. We used Cox proportional hazards models to estimate the hazard ratios (HR) and 95% confidence intervals (CIs) for the association between migraine and ovarian cancer risk in each cohort. In secondary analyses, we stratified by age and menopausal status. After adjusting for potential covariates, there was no statistically significant association between migraine and ovarian cancer risk in either the NHSII (HR = 1.29, 95%CI: 0.96, 1.74) or the WHS (HR = 0.60, 95%CI: 0.34, 1.06). In stratified analysis in the NHSII, there was a statistically significant positive association between migraine and ovarian cancer risk among women &lt;45 years of age (HR = 1.76, 95%CI: 1.01, 3.07). We did not observe a clear association between migraine and ovarian cancer risk in two large prospective cohort studies. What's new? Migraine is more common in women than men, giving rise to the idea that hormones, particularly changing estrogen levels, trigger the condition. Recent studies further suggest that migraine may be associated with hormonally related cancers. Here, in two prospective cohorts, the Nurses’ Health Study II (NHSII), involving women ages 25–42 at baseline, and the Women's Health Study, with women 45 years or older, migraine was assessed for associations specifically with ovarian cancer. Overall, no statistically significant relationship was detected. Stratified analyses in the NHSII cohort revealed a positive association between migraine and ovarian cancer risk in women under age 45.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>28929486</pmid><doi>10.1002/ijc.31062</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0002-8900-4889</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0020-7136
ispartof International journal of cancer, 2018-02, Vol.142 (3), p.534-539
issn 0020-7136
1097-0215
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5856461
source Wiley
subjects Age
Cancer
Carcinoma, Ovarian Epithelial
Cohort Studies
Estrogens
Female
Headache
Health risk assessment
Health risks
Humans
Invasiveness
Medical personnel
Medical research
Middle Aged
Migraine
Migraine Disorders - epidemiology
Neoplasms, Glandular and Epithelial - epidemiology
Nurses
Nurses - statistics & numerical data
Ovarian cancer
Ovarian carcinoma
Ovarian Neoplasms - epidemiology
Prospective Studies
Risk
Statistical analysis
Statistical models
Surveys and Questionnaires
United States - epidemiology
Women's Health
Womens health
title Migraine and invasive epithelial ovarian cancer risk in the Nurses’ Health Study II and the Women's Health Study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T23%3A52%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Migraine%20and%20invasive%20epithelial%20ovarian%20cancer%20risk%20in%20the%20Nurses%E2%80%99%20Health%20Study%20II%20and%20the%20Women's%20Health%20Study&rft.jtitle=International%20journal%20of%20cancer&rft.au=Rice,%20Megan%20S.&rft.date=2018-02-01&rft.volume=142&rft.issue=3&rft.spage=534&rft.epage=539&rft.pages=534-539&rft.issn=0020-7136&rft.eissn=1097-0215&rft_id=info:doi/10.1002/ijc.31062&rft_dat=%3Cproquest_pubme%3E1974479896%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4432-54f6b192ace3d58342999529f92e6d6bd872dd1baefd689cab91d22abe0b24cb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1974479896&rft_id=info:pmid/28929486&rfr_iscdi=true